Rebif News
Most Popular Rebif Story
Who's next on the biotech buyout hit list?
Now that Biogen Idec is in play, the analysts are on the lookout for the next big acquisition target. Bear Stearns' Mark Read more...
Latest Headlines
- July 11, 2011
- October 16, 2007
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
